Product
PGN-EDO51
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
A Phase 2, Open-Label, Multiple Ascending Dose Study of PGN-EDO51 With a Long-Term Extension in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment (CONNECT1-EDO51)Status: Recruiting, Estimated PCD: 2025-03-01